Copyright Reports & Markets. All rights reserved.

Global Induced Pluripotent Stem Cells (iPSCs) Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Human iPSCs
      • 1.4.3 Mouse iPSCs
    • 1.5 Market by Application
      • 1.5.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2019-2025)
      • 1.5.2 Academic Research
      • 1.5.3 Drug Development and Discovery
      • 1.5.4 Toxicity Screening
      • 1.5.5 Regenerative Medicine
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Induced Pluripotent Stem Cells (iPSCs) Market Size
    • 2.2 Induced Pluripotent Stem Cells (iPSCs) Growth Trends by Regions
      • 2.2.1 Induced Pluripotent Stem Cells (iPSCs) Market Size by Regions (2019-2025)
      • 2.2.2 Induced Pluripotent Stem Cells (iPSCs) Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Induced Pluripotent Stem Cells (iPSCs) Market Size by by Players
      • 3.1.1 Global Induced Pluripotent Stem Cells (iPSCs) Revenue by by Players (2014-2019)
      • 3.1.2 Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Induced Pluripotent Stem Cells (iPSCs) Market Concentration Ratio (CR5 and HHI)
    • 3.2 Induced Pluripotent Stem Cells (iPSCs) Key Players Head office and Area Served
    • 3.3 Key Players Induced Pluripotent Stem Cells (iPSCs) Product/Solution/Service
    • 3.4 Date of Enter into Induced Pluripotent Stem Cells (iPSCs) Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2014-2019)
    • 4.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Induced Pluripotent Stem Cells (iPSCs) Market Size (2014-2019)
    • 5.2 Induced Pluripotent Stem Cells (iPSCs) Key Players in North America
    • 5.3 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
    • 5.4 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application

    6 Europe

    • 6.1 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size (2014-2019)
    • 6.2 Induced Pluripotent Stem Cells (iPSCs) Key Players in Europe
    • 6.3 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
    • 6.4 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application

    7 China

    • 7.1 China Induced Pluripotent Stem Cells (iPSCs) Market Size (2014-2019)
    • 7.2 Induced Pluripotent Stem Cells (iPSCs) Key Players in China
    • 7.3 China Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
    • 7.4 China Induced Pluripotent Stem Cells (iPSCs) Market Size by Application

    8 Japan

    • 8.1 Japan Induced Pluripotent Stem Cells (iPSCs) Market Size (2014-2019)
    • 8.2 Induced Pluripotent Stem Cells (iPSCs) Key Players in Japan
    • 8.3 Japan Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
    • 8.4 Japan Induced Pluripotent Stem Cells (iPSCs) Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size (2014-2019)
    • 9.2 Induced Pluripotent Stem Cells (iPSCs) Key Players in Southeast Asia
    • 9.3 Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
    • 9.4 Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size by Application

    10 India

    • 10.1 India Induced Pluripotent Stem Cells (iPSCs) Market Size (2014-2019)
    • 10.2 Induced Pluripotent Stem Cells (iPSCs) Key Players in India
    • 10.3 India Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
    • 10.4 India Induced Pluripotent Stem Cells (iPSCs) Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Induced Pluripotent Stem Cells (iPSCs) Market Size (2014-2019)
    • 11.2 Induced Pluripotent Stem Cells (iPSCs) Key Players in Central & South America
    • 11.3 Central & South America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
    • 11.4 Central & South America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application

    12 International Players Profiles

    • 12.1 Fujifilm Holding Corporation (CDI)
      • 12.1.1 Fujifilm Holding Corporation (CDI) Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Induced Pluripotent Stem Cells (iPSCs) Introduction
      • 12.1.4 Fujifilm Holding Corporation (CDI) Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2014-2019))
      • 12.1.5 Fujifilm Holding Corporation (CDI) Recent Development
    • 12.2 Ncardia
      • 12.2.1 Ncardia Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Induced Pluripotent Stem Cells (iPSCs) Introduction
      • 12.2.4 Ncardia Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2014-2019)
      • 12.2.5 Ncardia Recent Development
    • 12.3 Sumitomo Dainippon Pharma
      • 12.3.1 Sumitomo Dainippon Pharma Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Induced Pluripotent Stem Cells (iPSCs) Introduction
      • 12.3.4 Sumitomo Dainippon Pharma Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2014-2019)
      • 12.3.5 Sumitomo Dainippon Pharma Recent Development
    • 12.4 Astellas Pharma Inc
      • 12.4.1 Astellas Pharma Inc Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Induced Pluripotent Stem Cells (iPSCs) Introduction
      • 12.4.4 Astellas Pharma Inc Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2014-2019)
      • 12.4.5 Astellas Pharma Inc Recent Development
    • 12.5 Fate Therapeutics, Inc
      • 12.5.1 Fate Therapeutics, Inc Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Induced Pluripotent Stem Cells (iPSCs) Introduction
      • 12.5.4 Fate Therapeutics, Inc Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2014-2019)
      • 12.5.5 Fate Therapeutics, Inc Recent Development
    • 12.6 Pluricell Biotech
      • 12.6.1 Pluricell Biotech Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Induced Pluripotent Stem Cells (iPSCs) Introduction
      • 12.6.4 Pluricell Biotech Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2014-2019)
      • 12.6.5 Pluricell Biotech Recent Development
    • 12.7 Cell Inspire Biotechnology
      • 12.7.1 Cell Inspire Biotechnology Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Induced Pluripotent Stem Cells (iPSCs) Introduction
      • 12.7.4 Cell Inspire Biotechnology Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2014-2019)
      • 12.7.5 Cell Inspire Biotechnology Recent Development
    • 12.8 ReproCELL
      • 12.8.1 ReproCELL Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Induced Pluripotent Stem Cells (iPSCs) Introduction
      • 12.8.4 ReproCELL Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2014-2019)
      • 12.8.5 ReproCELL Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      This report focuses on the global Induced Pluripotent Stem Cells (iPSCs) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Induced Pluripotent Stem Cells (iPSCs) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Fujifilm Holding Corporation (CDI)
      Ncardia
      Sumitomo Dainippon Pharma
      Astellas Pharma Inc
      Fate Therapeutics, Inc
      Pluricell Biotech
      Cell Inspire Biotechnology
      ReproCELL

      Market segment by Type, the product can be split into
      Human iPSCs
      Mouse iPSCs

      Human iPSCs had a market share of 89% in 2018, followed by Mouse iPSCs.

      Market segment by Application, split into
      Academic Research
      Drug Development and Discovery
      Toxicity Screening
      Regenerative Medicine

      Academic Research is the largest segment of Induced Pluripotent Stem Cells (iPSCs) application,with a share of 32% in 2018.

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Induced Pluripotent Stem Cells (iPSCs) status, future forecast, growth opportunity, key market and key players.
      To present the Induced Pluripotent Stem Cells (iPSCs) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Induced Pluripotent Stem Cells (iPSCs) are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now